Dr. Gaballa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030
Education & Training
- Ain Shams Faculty of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2024 - Present
- TX State Medical License 2022 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy.Gohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, Aaron Seo, Lewis F Nasr
Clinical Lymphoma, Myeloma & Leukemia. 2025-04-01 - BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.Mahmoud R Gaballa, Omar Castaneda Puglianini, Adam Cohen, Dan Vogl, Alfred Chung
Blood Advances. 2025-03-11 - 1 citationsComparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.Doris K Hansen, Lauren C Peres, Danai Dima, Alicia Richards, Leyla Shune
Journal of Clinical Oncology. 2025-02-18
Press Mentions
- March 27, 2025: Spotlight on Breakthroughs from MD Anderson ResearchMarch 27th, 2025
- MD Anderson Research Highlights for March 27, 2025March 27th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: